MediLink Therapeutics
MediLink Therapeutics has 1 licensing announcement in this dataset, dated 2026-01-09.
- Country / operating region
- China
- Ticker
- 查無
- Headquarters
- 查無
- Founded
- 查無
- Business
- Biopharmaceutical research and development
- Website
- www.medilinkthera.com
Pipeline / products
| Asset / platform | Target | Modality | Stage at announcement | Announcement date |
|---|---|---|---|---|
| YL201 | B7-H3 | ADC | phase3 | 2026-01-09 |
Licensing deals
| Date | Counterparty | Asset / platform | Upfront | Near-term | Milestones | Potential total | Other disclosed terms |
|---|---|---|---|---|---|---|---|
| 2026-01-09 | Roche | YL201 | 查無 | 查無 | 查無 | 查無 | Combined upfront + near-term USD 570m |
| Counterparty | Territory | Royalties |
|---|---|---|
| Roche | Worldwide excluding mainland China, Hong Kong and Macau | Tiered royalties on net sales outside China. |
Asia ADC assets and licensing deals
Catalysts
查無
Latest monthly revenue
查無
Most advanced drug
查無
Drugnews analysis
查無